Cheryl Ackert-Bicknell
Concepts (345)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoporosis | 14 | 2023 | 227 | 3.790 |
Why?
| Bone Density | 30 | 2023 | 437 | 3.340 |
Why?
| Bone and Bones | 14 | 2023 | 286 | 2.150 |
Why?
| Quantitative Trait Loci | 19 | 2022 | 322 | 1.990 |
Why?
| Genome-Wide Association Study | 20 | 2023 | 1301 | 1.850 |
Why?
| Osteoblasts | 14 | 2021 | 112 | 1.220 |
Why?
| Femur | 10 | 2018 | 193 | 0.960 |
Why?
| Genetic Variation | 8 | 2019 | 888 | 0.950 |
Why?
| Zebrafish | 3 | 2023 | 419 | 0.910 |
Why?
| Mice | 54 | 2022 | 15075 | 0.890 |
Why?
| Chromosome Mapping | 10 | 2019 | 494 | 0.870 |
Why?
| Intervertebral Disc Degeneration | 1 | 2023 | 28 | 0.850 |
Why?
| Intervertebral Disc Displacement | 1 | 2023 | 36 | 0.850 |
Why?
| Intervertebral Disc | 1 | 2023 | 37 | 0.840 |
Why?
| Musculoskeletal Diseases | 1 | 2023 | 55 | 0.830 |
Why?
| Animals | 64 | 2023 | 32091 | 0.740 |
Why?
| Osteoporotic Fractures | 2 | 2022 | 57 | 0.690 |
Why?
| Spine | 2 | 2018 | 141 | 0.680 |
Why?
| Genome | 3 | 2019 | 258 | 0.670 |
Why?
| Insulin-Like Growth Factor I | 9 | 2008 | 285 | 0.660 |
Why?
| Fracture Healing | 2 | 2016 | 76 | 0.640 |
Why?
| Fractures, Bone | 4 | 2022 | 368 | 0.640 |
Why?
| Mice, Inbred C57BL | 16 | 2020 | 4770 | 0.610 |
Why?
| Alternative Splicing | 1 | 2018 | 186 | 0.560 |
Why?
| Skeleton | 1 | 2016 | 6 | 0.560 |
Why?
| Polymorphism, Single Nucleotide | 17 | 2021 | 2016 | 0.540 |
Why?
| PPAR gamma | 5 | 2010 | 186 | 0.540 |
Why?
| Diphosphonates | 1 | 2016 | 50 | 0.520 |
Why?
| Laboratory Animal Science | 1 | 2015 | 4 | 0.520 |
Why?
| Bone Density Conservation Agents | 1 | 2016 | 61 | 0.510 |
Why?
| Gene-Environment Interaction | 2 | 2013 | 195 | 0.490 |
Why?
| Lipoproteins, HDL | 2 | 2013 | 76 | 0.450 |
Why?
| Disease Models, Animal | 7 | 2017 | 3565 | 0.440 |
Why?
| Body Composition | 6 | 2010 | 591 | 0.430 |
Why?
| Phenotype | 18 | 2021 | 2854 | 0.430 |
Why?
| Aging | 5 | 2021 | 1636 | 0.420 |
Why?
| GATA Transcription Factors | 1 | 2012 | 8 | 0.410 |
Why?
| Hip | 1 | 2012 | 46 | 0.400 |
Why?
| Cholesterol, HDL | 1 | 2012 | 185 | 0.380 |
Why?
| Mice, Inbred C3H | 9 | 2010 | 239 | 0.380 |
Why?
| Mice, Inbred Strains | 9 | 2015 | 401 | 0.380 |
Why?
| Genetic Predisposition to Disease | 7 | 2022 | 2202 | 0.370 |
Why?
| DNA-Binding Proteins | 3 | 2020 | 1308 | 0.370 |
Why?
| Gene Regulatory Networks | 3 | 2021 | 236 | 0.370 |
Why?
| Transcription Factors | 4 | 2023 | 1531 | 0.370 |
Why?
| Thiazolidinediones | 2 | 2008 | 144 | 0.360 |
Why?
| Chromosome Inversion | 2 | 2007 | 15 | 0.360 |
Why?
| Dietary Fats | 2 | 2011 | 299 | 0.360 |
Why?
| Crosses, Genetic | 6 | 2012 | 137 | 0.340 |
Why?
| Carrier Proteins | 5 | 2017 | 706 | 0.320 |
Why?
| Gene Expression Regulation | 9 | 2020 | 2366 | 0.310 |
Why?
| Genetic Association Studies | 3 | 2016 | 349 | 0.290 |
Why?
| Cell Differentiation | 6 | 2021 | 1710 | 0.290 |
Why?
| Chromosomes, Mammalian | 4 | 2012 | 26 | 0.290 |
Why?
| Osteogenesis | 4 | 2021 | 188 | 0.280 |
Why?
| Humans | 35 | 2023 | 115297 | 0.280 |
Why?
| Mice, Knockout | 9 | 2020 | 2607 | 0.270 |
Why?
| Genetic Pleiotropy | 2 | 2017 | 30 | 0.250 |
Why?
| Meta-Analysis as Topic | 2 | 2017 | 163 | 0.240 |
Why?
| Adipose Tissue | 2 | 2007 | 558 | 0.240 |
Why?
| Calcification, Physiologic | 2 | 2021 | 34 | 0.230 |
Why?
| Bone Diseases | 2 | 2015 | 58 | 0.230 |
Why?
| Longevity | 2 | 2015 | 137 | 0.230 |
Why?
| X-Ray Microtomography | 4 | 2018 | 79 | 0.230 |
Why?
| Allelic Imbalance | 1 | 2023 | 7 | 0.230 |
Why?
| Craniosynostoses | 1 | 2023 | 28 | 0.220 |
Why?
| CRISPR-Cas Systems | 1 | 2023 | 84 | 0.220 |
Why?
| Organ Size | 4 | 2017 | 438 | 0.220 |
Why?
| Exons | 2 | 2018 | 298 | 0.210 |
Why?
| Behavior, Animal | 2 | 2016 | 470 | 0.210 |
Why?
| Femoracetabular Impingement | 1 | 2022 | 36 | 0.210 |
Why?
| Osteoarthritis, Hip | 1 | 2022 | 40 | 0.210 |
Why?
| HMGB1 Protein | 1 | 2022 | 46 | 0.200 |
Why?
| Biology | 1 | 2023 | 78 | 0.200 |
Why?
| Skull | 3 | 2023 | 121 | 0.200 |
Why?
| Cell Culture Techniques | 2 | 2022 | 346 | 0.200 |
Why?
| Mammals | 1 | 2023 | 251 | 0.200 |
Why?
| Regenerative Medicine | 1 | 2022 | 41 | 0.200 |
Why?
| Erythropoietin | 1 | 2022 | 72 | 0.200 |
Why?
| Musculoskeletal System | 1 | 2022 | 44 | 0.200 |
Why?
| Bone Marrow | 2 | 2015 | 247 | 0.190 |
Why?
| Genotype | 5 | 2018 | 1832 | 0.190 |
Why?
| Anemia | 1 | 2022 | 144 | 0.190 |
Why?
| Computational Biology | 2 | 2021 | 525 | 0.180 |
Why?
| Antibody-Producing Cells | 1 | 2020 | 29 | 0.180 |
Why?
| Male | 26 | 2021 | 55796 | 0.180 |
Why?
| Female | 33 | 2021 | 59773 | 0.180 |
Why?
| Muscle Weakness | 1 | 2021 | 81 | 0.180 |
Why?
| Adipogenesis | 2 | 2010 | 45 | 0.180 |
Why?
| Cell Separation | 1 | 2021 | 290 | 0.170 |
Why?
| Antibodies, Bacterial | 1 | 2020 | 119 | 0.170 |
Why?
| Sarcopenia | 1 | 2021 | 68 | 0.170 |
Why?
| Tetraspanins | 1 | 2019 | 15 | 0.170 |
Why?
| Sex Characteristics | 2 | 2018 | 642 | 0.170 |
Why?
| Transcriptome | 5 | 2022 | 745 | 0.160 |
Why?
| Cartilage, Articular | 1 | 2022 | 296 | 0.160 |
Why?
| Promoter Regions, Genetic | 2 | 2018 | 1127 | 0.160 |
Why?
| Osteomyelitis | 1 | 2020 | 105 | 0.160 |
Why?
| Untranslated Regions | 1 | 2018 | 4 | 0.160 |
Why?
| RAW 264.7 Cells | 1 | 2018 | 41 | 0.160 |
Why?
| Information Management | 1 | 2018 | 15 | 0.160 |
Why?
| Cell Line | 5 | 2018 | 2628 | 0.150 |
Why?
| Musculoskeletal Development | 1 | 2017 | 5 | 0.150 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 55 | 0.150 |
Why?
| Nuclear Proteins | 3 | 2011 | 591 | 0.150 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 6 | 0.150 |
Why?
| Oncogene Proteins, Fusion | 1 | 2019 | 177 | 0.150 |
Why?
| Genetic Markers | 2 | 2016 | 339 | 0.150 |
Why?
| Quantitative Trait, Heritable | 2 | 2018 | 119 | 0.150 |
Why?
| Calcaneus | 1 | 2017 | 59 | 0.140 |
Why?
| Leukocytes | 1 | 2018 | 279 | 0.140 |
Why?
| Excitatory Amino Acid Transporter 1 | 1 | 2016 | 4 | 0.140 |
Why?
| Receptor, EphB2 | 1 | 2016 | 4 | 0.140 |
Why?
| Glycoproteins | 3 | 2003 | 308 | 0.140 |
Why?
| Species Specificity | 5 | 2014 | 551 | 0.140 |
Why?
| Animals, Outbred Strains | 1 | 2016 | 3 | 0.140 |
Why?
| Retinal Vessels | 1 | 2017 | 51 | 0.140 |
Why?
| Wnt Proteins | 2 | 2015 | 139 | 0.140 |
Why?
| Staphylococcus aureus | 1 | 2020 | 386 | 0.140 |
Why?
| Pelvic Bones | 1 | 2019 | 124 | 0.140 |
Why?
| Minerals | 1 | 2016 | 37 | 0.140 |
Why?
| Histological Techniques | 1 | 2016 | 40 | 0.140 |
Why?
| Mutagenesis | 1 | 2017 | 172 | 0.140 |
Why?
| Sepsis | 1 | 2022 | 519 | 0.140 |
Why?
| Databases, Genetic | 2 | 2014 | 199 | 0.140 |
Why?
| Immunoglobulin G | 1 | 2020 | 779 | 0.140 |
Why?
| Staphylococcal Infections | 1 | 2020 | 338 | 0.140 |
Why?
| Program Development | 1 | 2018 | 346 | 0.130 |
Why?
| Osteoarthritis | 1 | 2018 | 173 | 0.130 |
Why?
| Stem Cells | 2 | 2022 | 542 | 0.130 |
Why?
| Rodent Diseases | 1 | 2015 | 25 | 0.130 |
Why?
| Animal Structures | 1 | 2015 | 7 | 0.130 |
Why?
| Spinal Fractures | 1 | 2016 | 78 | 0.130 |
Why?
| Bone Resorption | 1 | 2016 | 80 | 0.130 |
Why?
| Haplotypes | 3 | 2012 | 467 | 0.130 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2021 | 798 | 0.120 |
Why?
| Gene Expression Profiling | 4 | 2017 | 1567 | 0.120 |
Why?
| Rats | 1 | 2023 | 5033 | 0.120 |
Why?
| Fracture Fixation, Intramedullary | 1 | 2015 | 55 | 0.120 |
Why?
| Linkage Disequilibrium | 3 | 2021 | 266 | 0.120 |
Why?
| Transcription, Genetic | 4 | 2020 | 1311 | 0.120 |
Why?
| Urodynamics | 1 | 2014 | 29 | 0.120 |
Why?
| Face | 1 | 2015 | 166 | 0.120 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 58 | 0.120 |
Why?
| Mice, Transgenic | 3 | 2015 | 1973 | 0.120 |
Why?
| Urination | 1 | 2014 | 40 | 0.120 |
Why?
| Inbreeding | 2 | 2011 | 16 | 0.110 |
Why?
| Genomics | 3 | 2015 | 638 | 0.110 |
Why?
| Animals, Newborn | 4 | 2021 | 785 | 0.110 |
Why?
| Genome, Human | 1 | 2015 | 372 | 0.110 |
Why?
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2013 | 11 | 0.110 |
Why?
| Lower Urinary Tract Symptoms | 1 | 2014 | 47 | 0.110 |
Why?
| Databases, Factual | 1 | 2018 | 1157 | 0.110 |
Why?
| Ovariectomy | 2 | 2011 | 120 | 0.110 |
Why?
| Adipocytes | 3 | 2010 | 191 | 0.110 |
Why?
| Bone Marrow Cells | 4 | 2010 | 272 | 0.110 |
Why?
| Sequence Analysis, DNA | 3 | 2015 | 730 | 0.100 |
Why?
| Liver | 6 | 2012 | 1716 | 0.100 |
Why?
| RNA Editing | 1 | 2012 | 20 | 0.100 |
Why?
| Stromal Cells | 4 | 2006 | 99 | 0.100 |
Why?
| Lod Score | 1 | 2012 | 71 | 0.100 |
Why?
| Adipose Tissue, White | 1 | 2012 | 35 | 0.100 |
Why?
| Homeodomain Proteins | 1 | 2015 | 465 | 0.100 |
Why?
| Inflammation | 2 | 2022 | 2482 | 0.100 |
Why?
| Environment | 1 | 2013 | 340 | 0.100 |
Why?
| Gastrointestinal Microbiome | 1 | 2018 | 524 | 0.100 |
Why?
| 3' Untranslated Regions | 1 | 2012 | 139 | 0.100 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2003 | 196 | 0.100 |
Why?
| Membrane Glycoproteins | 2 | 2003 | 429 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2019 | 2811 | 0.090 |
Why?
| Myogenic Regulatory Factors | 1 | 2010 | 49 | 0.090 |
Why?
| MEF2 Transcription Factors | 1 | 2010 | 55 | 0.090 |
Why?
| Severity of Illness Index | 1 | 2018 | 2598 | 0.090 |
Why?
| Circadian Rhythm | 2 | 2010 | 371 | 0.090 |
Why?
| Sequence Analysis, RNA | 2 | 2022 | 396 | 0.090 |
Why?
| Research Design | 1 | 2015 | 947 | 0.080 |
Why?
| Estrogens | 1 | 2012 | 323 | 0.080 |
Why?
| Bone Development | 2 | 2014 | 52 | 0.080 |
Why?
| Repressor Proteins | 1 | 2012 | 370 | 0.080 |
Why?
| Mice, Inbred DBA | 1 | 2008 | 173 | 0.080 |
Why?
| RNA, Messenger | 7 | 2019 | 2579 | 0.080 |
Why?
| Cohort Studies | 3 | 2021 | 4960 | 0.080 |
Why?
| Alleles | 2 | 2008 | 812 | 0.080 |
Why?
| Gene Expression | 4 | 2019 | 1451 | 0.080 |
Why?
| Europe | 2 | 2021 | 350 | 0.080 |
Why?
| Models, Animal | 2 | 2014 | 343 | 0.070 |
Why?
| Molecular Sequence Annotation | 2 | 2017 | 74 | 0.070 |
Why?
| Somatomedins | 1 | 2006 | 27 | 0.070 |
Why?
| Cells, Cultured | 4 | 2020 | 3879 | 0.070 |
Why?
| Mutation | 1 | 2017 | 3371 | 0.070 |
Why?
| Bone Remodeling | 1 | 2006 | 64 | 0.070 |
Why?
| MicroRNAs | 1 | 2012 | 615 | 0.070 |
Why?
| Obesity | 1 | 2018 | 2562 | 0.060 |
Why?
| Keratins | 1 | 2006 | 174 | 0.060 |
Why?
| Mammary Glands, Animal | 1 | 2006 | 120 | 0.060 |
Why?
| Morphogenesis | 1 | 2006 | 161 | 0.060 |
Why?
| Granulosa Cell Tumor | 1 | 2003 | 6 | 0.060 |
Why?
| X Chromosome | 1 | 2003 | 46 | 0.060 |
Why?
| Genetic Diseases, X-Linked | 1 | 2003 | 23 | 0.060 |
Why?
| Adiposity | 1 | 2008 | 479 | 0.060 |
Why?
| Actins | 1 | 2006 | 381 | 0.060 |
Why?
| Lipids | 1 | 2007 | 577 | 0.060 |
Why?
| Transcription Initiation Site | 1 | 2023 | 41 | 0.060 |
Why?
| Oncogenes | 1 | 2003 | 104 | 0.060 |
Why?
| Uncertainty | 1 | 2023 | 96 | 0.050 |
Why?
| Osteoclasts | 2 | 2017 | 36 | 0.050 |
Why?
| Erythropoiesis | 1 | 2022 | 33 | 0.050 |
Why?
| Aged | 4 | 2022 | 19253 | 0.050 |
Why?
| Receptors, Erythropoietin | 1 | 2022 | 21 | 0.050 |
Why?
| Polymorphism, Genetic | 1 | 2005 | 627 | 0.050 |
Why?
| Protein Isoforms | 1 | 2023 | 337 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 942 | 0.050 |
Why?
| Body Weight | 3 | 2017 | 877 | 0.050 |
Why?
| Gene Ontology | 1 | 2021 | 45 | 0.050 |
Why?
| Hip Joint | 1 | 2022 | 130 | 0.050 |
Why?
| Growth Differentiation Factor 5 | 1 | 2021 | 2 | 0.050 |
Why?
| Bone Matrix | 1 | 2021 | 6 | 0.050 |
Why?
| HLA-DQ alpha-Chains | 1 | 2021 | 16 | 0.050 |
Why?
| Clinical Protocols | 1 | 2022 | 232 | 0.050 |
Why?
| Hypoglycemic Agents | 1 | 2008 | 1000 | 0.050 |
Why?
| Gene Frequency | 2 | 2015 | 505 | 0.050 |
Why?
| Wnt4 Protein | 1 | 2020 | 18 | 0.050 |
Why?
| Growth Hormone | 3 | 2006 | 99 | 0.050 |
Why?
| Cortical Bone | 1 | 2019 | 18 | 0.040 |
Why?
| ROC Curve | 1 | 2020 | 445 | 0.040 |
Why?
| Ovarian Neoplasms | 1 | 2003 | 416 | 0.040 |
Why?
| Bifidobacterium longum | 1 | 2018 | 5 | 0.040 |
Why?
| Nitric Oxide | 1 | 2003 | 830 | 0.040 |
Why?
| Oligosaccharides | 1 | 2018 | 47 | 0.040 |
Why?
| Muscle Strength | 1 | 2021 | 279 | 0.040 |
Why?
| Hip Fractures | 1 | 2019 | 75 | 0.040 |
Why?
| Glypicans | 1 | 2017 | 9 | 0.040 |
Why?
| Tissue Engineering | 1 | 2022 | 365 | 0.040 |
Why?
| Osteochondrodysplasias | 1 | 2017 | 15 | 0.040 |
Why?
| Osteocytes | 1 | 2017 | 22 | 0.040 |
Why?
| Electroretinography | 1 | 2017 | 40 | 0.040 |
Why?
| Growth Disorders | 1 | 2017 | 80 | 0.040 |
Why?
| Cancellous Bone | 1 | 2016 | 20 | 0.040 |
Why?
| RNA | 1 | 2022 | 816 | 0.030 |
Why?
| Homozygote | 1 | 2017 | 185 | 0.030 |
Why?
| Dysbiosis | 1 | 2018 | 147 | 0.030 |
Why?
| Genetic Loci | 1 | 2018 | 278 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 2012 | 991 | 0.030 |
Why?
| Age Factors | 2 | 2018 | 2908 | 0.030 |
Why?
| Mice, Congenic | 2 | 2006 | 21 | 0.030 |
Why?
| Middle Aged | 3 | 2021 | 26936 | 0.030 |
Why?
| Cryopreservation | 1 | 2016 | 93 | 0.030 |
Why?
| Disease Progression | 1 | 2022 | 2423 | 0.030 |
Why?
| Wnt Signaling Pathway | 1 | 2017 | 149 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2020 | 1805 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 757 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2015 | 273 | 0.030 |
Why?
| Base Sequence | 2 | 2012 | 2104 | 0.030 |
Why?
| Regression Analysis | 1 | 2018 | 962 | 0.030 |
Why?
| Mice, Inbred NZB | 2 | 2006 | 15 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2019 | 534 | 0.030 |
Why?
| Lumbar Vertebrae | 1 | 2016 | 217 | 0.030 |
Why?
| Genes, Reporter | 1 | 2015 | 259 | 0.030 |
Why?
| Exome | 1 | 2015 | 208 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2012 | 2773 | 0.030 |
Why?
| Tibial Fractures | 1 | 2015 | 69 | 0.030 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 2 | 2004 | 23 | 0.030 |
Why?
| Upper Extremity | 1 | 2014 | 78 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2017 | 1440 | 0.030 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2003 | 7 | 0.030 |
Why?
| Child | 3 | 2018 | 18435 | 0.030 |
Why?
| Fibrosis | 1 | 2015 | 455 | 0.030 |
Why?
| RANK Ligand | 2 | 2003 | 28 | 0.030 |
Why?
| Osteoprotegerin | 2 | 2003 | 23 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3035 | 0.030 |
Why?
| Biopsy | 1 | 2016 | 1053 | 0.030 |
Why?
| Receptors, Tumor Necrosis Factor | 2 | 2003 | 140 | 0.030 |
Why?
| Software | 1 | 2016 | 533 | 0.030 |
Why?
| Absorptiometry, Photon | 1 | 2013 | 220 | 0.030 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 63 | 0.030 |
Why?
| Models, Biological | 2 | 2010 | 1642 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 323 | 0.030 |
Why?
| Adult | 3 | 2019 | 30576 | 0.030 |
Why?
| Litter Size | 1 | 2011 | 16 | 0.020 |
Why?
| Macrophages | 1 | 2018 | 1273 | 0.020 |
Why?
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2010 | 12 | 0.020 |
Why?
| Biomechanical Phenomena | 2 | 2004 | 677 | 0.020 |
Why?
| Lower Extremity | 1 | 2014 | 338 | 0.020 |
Why?
| Risk Factors | 2 | 2016 | 8684 | 0.020 |
Why?
| Sex Factors | 1 | 2015 | 1734 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2013 | 1164 | 0.020 |
Why?
| 3T3-L1 Cells | 1 | 2010 | 33 | 0.020 |
Why?
| Biomarkers | 1 | 2020 | 3450 | 0.020 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2010 | 123 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2010 | 110 | 0.020 |
Why?
| Lipoproteins | 1 | 2010 | 160 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2021 | 6432 | 0.020 |
Why?
| Meiosis | 1 | 2009 | 60 | 0.020 |
Why?
| Artificial Intelligence | 1 | 2010 | 145 | 0.020 |
Why?
| Cluster Analysis | 1 | 2010 | 469 | 0.020 |
Why?
| Chromosomes | 1 | 2009 | 81 | 0.020 |
Why?
| Bayes Theorem | 1 | 2010 | 338 | 0.020 |
Why?
| Cell Lineage | 1 | 2010 | 311 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2014 | 2440 | 0.020 |
Why?
| Dissection | 1 | 2007 | 53 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2006 | 4 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2006 | 9 | 0.020 |
Why?
| Infant, Newborn | 1 | 2018 | 5060 | 0.020 |
Why?
| Insulin-Like Growth Factor II | 1 | 2006 | 23 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2006 | 38 | 0.020 |
Why?
| Receptor, IGF Type 1 | 1 | 2006 | 58 | 0.020 |
Why?
| Microarray Analysis | 1 | 2006 | 118 | 0.020 |
Why?
| Genetic Linkage | 1 | 2007 | 311 | 0.020 |
Why?
| Receptors, Somatotropin | 1 | 2005 | 8 | 0.020 |
Why?
| Cholesterol | 1 | 2007 | 368 | 0.020 |
Why?
| Triglycerides | 1 | 2007 | 479 | 0.020 |
Why?
| Sequence Alignment | 1 | 2005 | 328 | 0.020 |
Why?
| Infant | 1 | 2018 | 7955 | 0.020 |
Why?
| DNA Primers | 1 | 2006 | 514 | 0.020 |
Why?
| Brain | 1 | 2016 | 2371 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2006 | 720 | 0.020 |
Why?
| Stress, Mechanical | 1 | 2006 | 440 | 0.020 |
Why?
| Transfection | 1 | 2006 | 858 | 0.020 |
Why?
| Down-Regulation | 1 | 2006 | 603 | 0.010 |
Why?
| Child, Preschool | 1 | 2018 | 9124 | 0.010 |
Why?
| Alkaline Phosphatase | 1 | 2004 | 145 | 0.010 |
Why?
| Nitric Oxide Donors | 1 | 2003 | 15 | 0.010 |
Why?
| Guanylate Cyclase | 1 | 2003 | 32 | 0.010 |
Why?
| Nitroprusside | 1 | 2003 | 64 | 0.010 |
Why?
| Radiography | 1 | 2006 | 825 | 0.010 |
Why?
| Cyclic GMP | 1 | 2003 | 79 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1488 | 0.010 |
Why?
| Calcitriol | 1 | 2003 | 54 | 0.010 |
Why?
| Parathyroid Hormone | 1 | 2003 | 95 | 0.010 |
Why?
| Blotting, Western | 1 | 2006 | 1146 | 0.010 |
Why?
| Prospective Studies | 1 | 2014 | 6236 | 0.010 |
Why?
| Recombination, Genetic | 1 | 2003 | 171 | 0.010 |
Why?
| Phylogeny | 1 | 2006 | 799 | 0.010 |
Why?
| Pregnancy | 1 | 2014 | 5540 | 0.010 |
Why?
| Human Growth Hormone | 1 | 2002 | 37 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2006 | 1634 | 0.010 |
Why?
| Tibia | 1 | 2002 | 173 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2003 | 749 | 0.010 |
Why?
| Adolescent | 1 | 2018 | 17767 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2002 | 1241 | 0.010 |
Why?
| Kinetics | 1 | 2002 | 1549 | 0.010 |
Why?
| Young Adult | 1 | 2014 | 10413 | 0.010 |
Why?
| NF-kappa B | 1 | 2002 | 634 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 2005 | 1455 | 0.010 |
Why?
| Signal Transduction | 1 | 2006 | 4537 | 0.010 |
Why?
|
|
Ackert-Bicknell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|